Gillian Horne

7PUBLICATIONS
20CO-AUTHORS
Haematological tumoursGene and molecular therapyCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 19, 2024
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy.

Andrew J Innes, Chloe Hayden, Victoria Orovboni

|Sep 27, 2021
Multiple myeloma: therapeutic delivery of antibodies and aptamers.

Neret Pujol-Navarro, Mohammed M Al Qaraghuli, Karina Kubiak-Ossowska

|Feb 02, 2020
Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy.

Ross Kinstrie, Gillian A Horne, Heather Morrison

|Jan 12, 2020
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease.

G A Horne, J Stobo, C Kelly

|Jan 04, 2020
CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy.

Ross Kinstrie, Gillian A Horne, Heather Morrison

Pageof 2

Frequent Collaborators

4 joint publications

Mhairi Copland

2 joint publications

Paolo Gallipoli

2 joint publications

Eduardo Gómez Castañeda

2 joint publications

Karen Dunn